Clinical trial
The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active…
NCT00245505 · Ferring Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00245505 |
|---|---|
| Title | The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" |
| Official title | The Effect on Mucosal Healing With Pentasa Sachet 4g in Mild to Moderate Active Small Bowel Crohn´s Disease, Evaluated by Video Capsule Endoscopy After 6 and 12 Weeks Treatment. A Pilot Study |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Mesalazine (Mesalamine) |
| Enrollment | 3 |
| Start date | Feb 1, 2009 |
| Primary completion | Jun 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Oct 28, 2005 |
| Last update posted | Mar 12, 2012 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: